Skip to main content
Premium Trial:

Request an Annual Quote

Power3 Working with Jordan University to Validate Breast Cancer Dx

NEW YORK (GenomeWeb News) – Proteomic diagnostics company Power3 Medical Products is collaborating with the Princess Haya Biotechnology Center at the Jordan University of Science and Technology for a clinical validation study of the company’s BC-SeraPro Breast Cancer diagnostic blood test.
Under the program, the Princess Haya center and Jordan University will provide breast cancer, benign breast disease, and age-matched control patient samples that the company will analyze using its panel of protein biomarkers.
Power3 said it plans to finish the clinical validation study in the third quarter of this year and to launch the BC-SeraPro in the first quarter of 2009. The company said it aims to develop a protein biomarker-based diagnostic test that can be applied “regardless of a woman’s genetic makeup or ethnicity.”
Among women in Jordan, breast cancer is the leading form of cancer and the second leading cause of death.
Power3 also is involved in clinical evaluation studies for its NuroPro blood-based test for Parkinson’s disease with the University of Thessaly Medical School in Greece and at the Cleo Roberts Center for Clinical Research at the Sun Health Research Institute in Sun City, Arizona.
The company also said it expects to introduce the NuroPro diagnostic for Parkinson’s and Alzheimer’s diseases in international markets later this year and in the US soon afterward.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.